Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Zhonghua Yi Xue Za Zhi
|
September 14, 2013
[Transperitoneal laparoscopic ureterolithotomy for upper ureteral calculi: a report of 1171 cases]
Liang Ma, Da-min Yu, Zhi-gen Zhang, et al.
European Journal of Medicinal Chemistry
|
September 13, 2025
Discovery of a heterocyclic aromatic amide based P-gp inhibitor as coadjutant regulating autophagy against drug resistance in breast cancer
Wen-Han Xue, Xu Zhang, Shuai Guo, et al.
Bioorganic Chemistry
|
February 21, 2023
Design, synthesis and structure-activity relationship of N-phenyl aromatic amide derivatives as novel xanthine oxidase inhibitors
Sen-Sen Hu, Ting-Jian Zhang, Zhao-Ran Wang, et al.
European Journal of Medicinal Chemistry
|
February 20, 2026
Proline, a privileged fragment in drug design: advances and future perspectives
Ting-Ting Li, Li-Rong Liu, Gong-Hui Ge, et al.
Journal of Zhejiang University. Science. B
|
August 6, 2014
Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy
You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, et al.
Bioorganic Chemistry
|
December 12, 2025
Discovery of novel 2-azabicyclo[3.2.1]octane derivatives against non-small cell lung cancer from aconitine simplification
Shuai Guo, Ting-Ting Li, Gong-Hui Ge, et al.
Bioorganic & Medicinal Chemistry
|
March 24, 2026
Exploring the potential of heterocyclic-containing tail approach in the development of novel covalent inhibitors dual-targeting EGFR and HER-2: design, synthesis and biological evaluation
Shuang Hao, Jing-Han Yan, Rui Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2025
Discovery and structural-activity relationship of N-benzyl-2-fluorobenzamides as EGFR/HDAC3 dual-target inhibitors for the treatment of triple-negative breast cancer
Gong-Hui Ge, Shuai Guo, Ting-Ting Li, et al.
Archiv Der Pharmazie
|
July 4, 2024
Discovery of 4-(isopentyloxy)-3-nitrobenzamide derivatives as xanthine oxidase inhibitors through a non-anthraquinone exploration
Shuai Guo, Qi Sun, Xu Zhang, et al.
Journal of Cancer
|
April 1, 2020
The prognostic value of miRNA-18a-5p in clear cell renal cell carcinoma and its function via the miRNA-18a-5p/HIF1A/PVT1 pathway
Huan Wang, Zhong-Yi Li, Zu-Hao Xu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Zhonghua Yi Xue Za Zhi
|
September 14, 2013
[Transperitoneal laparoscopic ureterolithotomy for upper ureteral calculi: a report of 1171 cases]
Liang Ma, Da-min Yu, Zhi-gen Zhang, et al.
European Journal of Medicinal Chemistry
|
September 13, 2025
Discovery of a heterocyclic aromatic amide based P-gp inhibitor as coadjutant regulating autophagy against drug resistance in breast cancer
Wen-Han Xue, Xu Zhang, Shuai Guo, et al.
Bioorganic Chemistry
|
February 21, 2023
Design, synthesis and structure-activity relationship of N-phenyl aromatic amide derivatives as novel xanthine oxidase inhibitors
Sen-Sen Hu, Ting-Jian Zhang, Zhao-Ran Wang, et al.
European Journal of Medicinal Chemistry
|
February 20, 2026
Proline, a privileged fragment in drug design: advances and future perspectives
Ting-Ting Li, Li-Rong Liu, Gong-Hui Ge, et al.
Journal of Zhejiang University. Science. B
|
August 6, 2014
Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy
You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, et al.
Bioorganic Chemistry
|
December 12, 2025
Discovery of novel 2-azabicyclo[3.2.1]octane derivatives against non-small cell lung cancer from aconitine simplification
Shuai Guo, Ting-Ting Li, Gong-Hui Ge, et al.
Bioorganic & Medicinal Chemistry
|
March 24, 2026
Exploring the potential of heterocyclic-containing tail approach in the development of novel covalent inhibitors dual-targeting EGFR and HER-2: design, synthesis and biological evaluation
Shuang Hao, Jing-Han Yan, Rui Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2025
Discovery and structural-activity relationship of N-benzyl-2-fluorobenzamides as EGFR/HDAC3 dual-target inhibitors for the treatment of triple-negative breast cancer
Gong-Hui Ge, Shuai Guo, Ting-Ting Li, et al.
Archiv Der Pharmazie
|
July 4, 2024
Discovery of 4-(isopentyloxy)-3-nitrobenzamide derivatives as xanthine oxidase inhibitors through a non-anthraquinone exploration
Shuai Guo, Qi Sun, Xu Zhang, et al.
Journal of Cancer
|
April 1, 2020
The prognostic value of miRNA-18a-5p in clear cell renal cell carcinoma and its function via the miRNA-18a-5p/HIF1A/PVT1 pathway
Huan Wang, Zhong-Yi Li, Zu-Hao Xu, et al.
Page
of 5